A monoclonal antibody developed by GlaxoSmithKline and Vir Biotechnology successfully counteracts a new strain of SARS-CoV-2.
Omicron variant
Posted inCOVID-19, Infections, Regulatory
Molnupiravir: What U.S. Experts Said
FDA scientists took a detailed look at molnupiravir for treating COVID-19.